Somerset, 23rd April, 2020 –
Somerset Pharma is pleased to announce the launch of Succinylcholine Chloride Injection in glass vial. Succinylcholine is used as an adjunct to general anesthesia.
Somerset continues to support the healthcare community by launching this critical drug that will be required during these challenging times. It is our goal to meet the demand for such medicine during the COVID-19 pandemic.
Succinylcholine injection is supplied as clear colorless solution in concentration of 20mg/ml in 10 ml vials. The company is launching Succinylcholine injection USP in packs of 25s and 10s.
With this product Somerset now has 22 products aggregating to 51 different presentations in the market with an additional 45 products in pipeline.
About Somerset Pharma
Somerset Pharma is a New Jersey based pharmaceutical company specializing in sterile products. Somerset manufactures and markets injectable and ophthalmic drugs for the U.S. marketplace. Somerset is committed to quality and aims to deliver affordable pharmaceuticals to all customers in the marketplace.
For additional information, please visit us https://somersetpharma.com/ or contact by email at firstname.lastname@example.org.